Biomarkers of Inflammation among Patients with COVID-19: A Single-Centre Prospective Study from Prishtina, Kosovo

Table 1

Demographic and clinical parameters of COVID-19 patients.

Parameters		Patients
Sex N (%)	Female	36 (41.9)
	Male	50 (58.1)
Age	Median (IQR)	62 (50–67)
Hospitalisation N (%)	Yes	73 (84.9)
Days of hospitalisation	Median (IQR)	11.50 (9.00–15.00)
Days prior to hospitalisation	Median (IQR)	6.00 (3.00–8.75)
Pulmonary infiltrates	Yes	65 (75.6)
Oxygen therapy	Yes	52 (60.5)
Disease severity N (%)	Mild	9 (10.5)
	Moderate	23 (26.7)
	Severe	50 (58.1)
	Critical	4 (4.7)
Medications used during illness N (%)	Corticosteroids	71 (82.6)
	Antivirals	45 (52.3)
	Antibiotics	82 (95.3)
Comorbidities N (%)	Hypertension	37 (43.0)
	Diabetes	15 (17.4)
	Cancer	7 (8.1)
	Hypothyroidism	2 (2.3)
Outcome N (%)	Recovery	82 (95.3)
	Death	4 (4.7)